Carboplatin/Etoposide/VincristineLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2047卷 / 1期

关键词：

D O I：

10.1007/s40278-025-77889-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：104 / 104

相关论文

共 50 条

[21] Carboplatin/etoposide/imatinibLack of efficacy: case report
Reactions Weekly, 2022, 1912 (1) : 135 - 135
[22] Carboplatin/etoposide/temozolomideLack of efficacy: case report
Reactions Weekly, 2022, 1936 (1) : 134 - 134
[23] Carboplatin/Etoposide/VismodegibLack of efficacy: case report
Reactions Weekly, 2024, 2032 (1) : 111 - 111
[24] Carboplatin/etoposide/paclitaxelLack of efficacy: case report
Reactions Weekly, 2022, 1917 (1) : 155 - 155
[25] VincristineLack of efficacy: case report
Reactions Weekly, 2023, 1956 (1) : 504 - 504
[26] Carboplatin/etoposide/toripalimabLack of efficacy and hypophysitis: case report
Reactions Weekly, 2023, 1957 (1) : 119 - 119
[27] Carboplatin/selumetinib/vincristineLack of efficacy
Reactions Weekly, 2024, 2004 (1) : 123 - 123
[28] Cytarabine/etoposide/vincristineLack of efficacy during treatment of acute myeloid leukaemia: case report
Reactions Weekly, 2022, 1893 (1) : 113 - 113
[29] Carboplatin/etoposide/gefitinibAcquired resistance and lack of efficacy: case report
Reactions Weekly, 2023, 1945 (1) : 150 - 150
[30] Carboplatin/etoposide/immune-globulinLack of efficacy: case report
Reactions Weekly, 2025, 2051 (1) : 81 - 81

← 1 2 3 4 5 →